PeerVoice Oncology & Haematology Video artwork

The Next Frontier in Immunotherapy for Multiple Myeloma: What Will BCMA Targeting Mean for Our Relapsed/Refractory Patients?

PeerVoice Oncology & Haematology Video

English - July 15, 2022 23:00 - 15 minutes - ★★★★★ - 1 rating
Science medical education peervoice oncology haematology hematology cancer Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Practical Guidance for Identifying and Managing Patients With Advanced MET Exon 14-Skipping NSCLC

Next Episode: Current and Emerging Radiopharmaceuticals for Prostate Cancer: Is There a Role for Both?

The Next Frontier in Immunotherapy for Multiple Myeloma: What Will BCMA Targeting Mean for Our Relapsed/Refractory Patients?